# IMMUNOCORE HLDGS PLC (IMCR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IMCR/

- Reporting holders: 4
- Reported value: $273.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [JUNCTURE WEALTH STRATEGIES, LLC](https://holderbook.com/funds/1632866-juncture-wealth-strategies-llc/) | $206.6K | 6,821 | 0.1% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $64.8K | 2,140 | 0.0% | 12 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $818 | 27 | 0.0% | 4 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $727 | 24 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $273.0K |
| Q2 2026 | 137 | $1.7B |
| Q1 2026 | 144 | $1.6B |
| Q4 2025 | 152 | $1.8B |
| Q3 2025 | 136 | $1.9B |
| Q2 2025 | 134 | $1.5B |
| Q1 2025 | 120 | $1.4B |
| Q4 2024 | 118 | $1.3B |
| Q3 2024 | 131 | $1.4B |
| Q2 2024 | 143 | $1.5B |
| Q1 2024 | 157 | $2.8B |
| Q4 2023 | 140 | $2.7B |